Viking Therapeutics’ stock soars 18% as data on oral weight loss drug looms

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers

The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.

Business - MarketWatch - 3 hours ago

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - November 13

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - 5 days ago

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - 6 days ago

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - 2 days ago

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - 2 days ago

More Large U.S. Employer Health Plans Covering Weight-Loss Drugs

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs such as Wegovy, Ozempic, and Zepbound.

Business - Inc. - 21 hours ago

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.

Business - MarketWatch - November 5

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

Science - The New York Times - 6 days ago

Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.

Business - MarketWatch - November 11

Tapestry’s stock soars and Capri erases losses as fashion giants scrap merger deal

Tapestry Inc.’ stock soared Thursday, while Capri Holdings Inc.’s stock erased losses to gain 4%, after Tapestry said it’s terminating its $8.5 billion merger agreement with its smaller rival.

Business - MarketWatch - 6 days ago

Stocks soar on Trump win

Welcome to The Hill's Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story Trump victory sends stocks, crypto soaring Stocks skyrocketed Wednesday after ...

Politics - The Hill - November 6

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

Hoping for a weight-loss pill? It could get closer to reality next week.

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.

Business - MarketWatch - November 2

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

Mother-of-two dies during Turkey weight-loss op

Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Phunware’s stock soars on Donald Trump’s election victory

Shares of mobile-advertising company Phunware have soared in recent weeks.

Business - MarketWatch - November 6

Stocks soar after decisive Trump victory

Major stock indexes soared Wednesday morning in the wake of Donald Trump's decisive victory in Tuesday's presidential election.

Crude oil heads to weekly loss as looming surplus depresses market

U.S. crude oil is down more than 2% this week, while Brent has shed nearly 2%.

Business - CNBC - 6 days ago

DJT stock soars amid Donald Trump's rise in the betting markets

Trump Media's shares have soared with the former President Donald Trump's rise in the betting markets.

Alphabet quiets the doubters with ‘all-around’ strength that sends stock soaring

“We believe that this ship is sailing smoothly and doing everything right,” an analyst says.

Business - MarketWatch - October 30

Roblox’s stock soars on third-quarter bookings beat and raised guidance

Roblox shares rose after the online gaming company reported better-than-expected third-quarter bookings and raised its full-year guidance.

Business - MarketWatch - October 31

Wayfair customers are more price conscious, have cut spending as election nears

Wayfair’s stock turned lower as some downbeat comments about the home-goods seller’s customers followed an earnings beat.

Business - MarketWatch - November 1

Bank stocks soar as Trump victory expected to lead to looser regulatory backdrop

Banks have been pushing all year to loosen capital requirements and are also expected to benefit from potential tax cuts.

Business - MarketWatch - November 6

AppLovin, top tech stock of the year, soars another 46% on earnings beat

AppLovin was already the best-performing tech stock of 2024, and that was before the stock popped on a big earnings beat.

Business - CNBC - November 7

Latest in Viking Therapeutics’ stock soars 18% as data on oral weight loss drug looms